Erratum: HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3.

Yuanyuan Li,Han Lei,Rihan Hai,Guang Shu,Wenguang Yan,Gang Yin

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 4602 in vol. 12, PMID: 36381312.].

What problem does this paper attempt to address?

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Erratum: Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.

Dong Lan,Li Wang,Rongquan He,Jie Ma,Yehong Bin,Xiaojv Chi,Gang Chen,Zhengwen Cai

2018-01-01

American journal of translational research

Abstract:[This corrects the article on p. 1295 in vol. 10, PMID: 29887946.].
HOXC10 Promotes Carboplatin Resistance of Ovarian Cancer by Regulating ABCC3.

Yuanyuan Li,Han Lei,Rihan Hai,Guang Shu,Wenguang Yan,Gang Yin

2022-01-01

Abstract:HOXC10 has been reported to be upregulated in ovarian cancer (OC) tissues, attributing to the metastasis of OC. However, the specific functions of HOXC10 in OC, especially its role in chemoresistance, remain to be determined. Therefore, in this study, we explored the function and the underlying mechanisms of HOXC10 in carboplatin resistance of OC. A variety of approaches were utilized to analyze the expression of HOXC10 and its related genes. The effect of HOXC10 in cell growth and chemoresistance was investigated in carboplatin-resistant OC subline TOV21G-R and the parental TOV21G-P cells. ROC curve and survival analysis were conducted to determine the predictive value of HOXC10 and ABCC3 combination in carboplatin resistance and the prognosis of OC. Luciferase reporter assay and Chromatin immunoprecipitation (ChIP) assay were used to explore the direct regulation of β-catenin by HOXC10. Our results demonstrated that the expression of HOXC10 was upregulated both in the carboplatin-resistant OC tissues and TOV21G-R cells. Furthermore, the upregulation of HOXC10 could promote the expression of ABCC3 by transcriptionally upregulating β-catenin. Moreover, overexpression of HOXC10 could decrease the sensitivity of cells to carboplatin, while knocking down HOXC10 had the opposite effect both in vitro and in vivo. Therefore, the expression of HOXC10/ABCC3 could be a novel biomarker for predicting the carboplatin resistance and the prognosis of OC patients.
Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Hongzhi Li,Weihua Yuan,Shufang Bin,Guang Wu,Panyuan Li,Min Liu,Jifeng Yang,Xiang Li,Kaiyan Yang,Haihua Gu

2022-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 688 in vol. 10, PMID: 32195036.].
Erratum: the FoxO–BNIP3 Axis Exerts a Unique Regulation of Mtorc1 and Cell Survival under Energy Stress

A Lin,J Yao,L Zhuang,D Wang,J Han,E W-F Lam,B Gan

DOI: https://doi.org/10.1038/onc.2014.330

IF: 8.756

2014-01-01

Oncogene

Abstract:Correction to: Oncogene (2014) 33, 3183–3194; doi:10.1038/onc.2013.273; published online 15 July 2013 Since the publication of this article The Cancer Genome Atlas (TCGA) has reported that they did not approve the inclusion of their name as co-author in the author list. TCGA has requested that ‘TCGAResearch Network’ be removed from the author list.
Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Xuan Wei,Juanjuan Shi,Qianhan Lin,Xiaoxue Ma,Yingxin Pang,Hongluan Mao,Rui Li,Wei Lu,Yu Wang,Peishu Liu

DOI: https://doi.org/10.3389/fonc.2021.742374

IF: 4.7

2021-09-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.642229.].

oncology
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Erratum: CXCL12 Chemokine Expression Suppresses Human Breast Cancer Growth and Metastasis in Vitro and in Vivo.

Zhi-Dong Lv,Bin Kong,Xiang-Ping Liu,Qian Dong,Hai-Tao Niu,Yong-Hua Wang,Fu-Nian Li,Hai-Bo Wang

DOI: https://doi.org/10.62347/gevx3778

2024-01-01

Abstract:[This corrects the article on p. 6671 in vol. 7, PMID: 25400746.].
Erratum: Ophiopogonin-B Suppresses Epithelial-mesenchymal Transition in Human Lung Adenocarcinoma Cells via the Linc00668/miR-432-5p/EMT Axis: Erratum

Cheng Hu,Rilei Jiang,Ziyu Cheng,Yueyang Lu,Ling Gu,Hongxiao Li,Liqiu Li,Qian Gao,Meijuan Chen,Xu Zhang

DOI: https://doi.org/10.7150/jca.98604

2024-06-01

Abstract:[This corrects the article DOI: 10.7150/jca.31338.].
Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Jun Li,Sile Han,Cuiyun Zhang,Yanlin Luo,Li Wang,Ping Wang,Yi Wang,Qingxin Xia,Xiaoyan Wang,Bing Wei,Jie Ma,Hongle Li,Yongjun Guo

DOI: https://doi.org/10.3389/fonc.2021.840551

IF: 4.7

2022-01-14

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.655709.].

oncology
Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma: Erratum

An Song,Yuanyuan Wu,Weiming Chu,Xueming Yang,Zaiou Zhu,Enshi Yan,Wei Zhang,Junbo Zhou,Xu Ding,Jie Liu,Hongxia Zhu,Jinhai Ye,Yunong Wu,Yang Zheng,Xiaomeng Song

DOI: https://doi.org/10.7150/ijbs.94832

2024-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.54014.].

biochemistry & molecular biology
Erratum: KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p: Erratum.

Mimi Zhou,Jinqiu Chen,Hui Zhang,Hailing Liu,Huan Yao,Xiaman Wang,Wanggang Zhang,Yingren Zhao,Nan Yang

DOI: https://doi.org/10.7150/ijbs.77067

2022-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.45999.].
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum

Jiang-Kai Dong,Hui-Min Lei,Qian Liang,Ya-Bin Tang,Ye Zhou,Yang Wang,Shengzhe Zhang,Wen-Bin Li,Yunguang Tong,Guanglei Zhuang,Liang Zhang,Hong-Zhuan Chen,Liang Zhu,Ying Shen

DOI: https://doi.org/10.7150/thno.58558

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.23177.].

medicine, research & experimental
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum

Libin Yan,Beichen Ding,Haoran Liu,Yangjun Zhang,Jin Zeng,Junhui Hu,Weimin Yao,Gan Yu,Ruihua An,Zhiqiang Chen,Zhangqun Ye,Jinchun Xing,Kefeng Xiao,Lily Wu,Hua Xu

DOI: https://doi.org/10.7150/thno.68810

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.37628.].

medicine, research & experimental
Erratum: N6-methyladenosine-induced ERRγ Triggers Chemoresistance of Cancer Cells Through Upregulation of ABCB1 and Metabolic Reprogramming: Erratum.

Zhuojia Chen,Long Wu,Jiawang Zhou,Xinyao Lin,Yanxi Peng,Lichen Ge,Cheng-Ming Chiang,Hui Huang,Hongsheng Wang,Weiling He

DOI: https://doi.org/10.7150/thno.85930

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.40144.].
Erratum - MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.

J Zhang,J Luo,J Ni,L Tang,H P Zhang,L Zhang,J F Xu,D Zheng

DOI: https://doi.org/10.4081/ejh.2024.4109

2024-01-01

Abstract:This corrects the article published in the European Journal of Histochemistry 2014;58:2262. doi: 10.4081/ejh.2014.2262.
Correction: Cepharanthine Hydrochloride Reverses the Mdr1 (P-Glycoprotein)-mediated Esophageal Squamous Cell Carcinoma Cell Cisplatin Resistance Through JNK and P53 Signals

Pengjun Zhou,Rong Zhang,Ying Wang,Dandan Xu,Li Zhang,Jinhong Qin,Guifeng Su,Yue Feng,Hongce Chen,Siyuan You,Wen Rui,Huizhong Liu,Suhong Chen,Hongyuan Chen,Yifei Wang

DOI: https://doi.org/10.18632/oncotarget.27638

2021-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.22676.].
Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.

Xiwei Ding,Yiyang Zhang,Tianlu Huang,Guifang Xu,Chunyan Peng,Gang Chen,Bo Kong,Helmut Friess,Shanshan Shen,Ying Lv,Lewis R Roberts,Lei Wang,Xiaoping Zou

2023-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 546 in vol. 9, PMID: 30949409.].
Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients

Jun Tang,Rong Deng,Rong-Zhen Luo,Guo-Ping Shen,Mu-Yan Cai,Zi-Ming Du,Shan Jiang,Ming-Tian Yang,Jian-Hua Fu,Xiao-Feng Zhu

DOI: https://doi.org/10.1007/s10549-016-3703-5

2016-01-01

Breast Cancer Research and Treatment

Abstract:Erratum to: Breast Cancer Res Treat (2012),134:549–560,DOI 10.1007/s10549-012-2080-y. In the original publication of the article, Fig. 5c was published incorrectly. The authors apologize for this error and the correct Fig. 5c is given below.
Erratum: The lncRNA HOXA11-AS Regulates Rab3D Expression by Sponging miR-125a-5p Promoting Metastasis of Osteosarcoma [Corrigendum]

DOI: https://doi.org/10.2147/CMAR.S353233

2021-12-23

Abstract:[This corrects the article DOI: 10.2147/CMAR.S196025.].

Erratum: HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3.

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Erratum: Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.

HOXC10 Promotes Carboplatin Resistance of Ovarian Cancer by Regulating ABCC3.

Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Erratum: the FoxO–BNIP3 Axis Exerts a Unique Regulation of Mtorc1 and Cell Survival under Energy Stress

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Erratum: CXCL12 Chemokine Expression Suppresses Human Breast Cancer Growth and Metastasis in Vitro and in Vivo.

Erratum: Ophiopogonin-B Suppresses Epithelial-mesenchymal Transition in Human Lung Adenocarcinoma Cells via the Linc00668/miR-432-5p/EMT Axis: Erratum

Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma: Erratum

Erratum: KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p: Erratum.

Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum

Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum

Erratum: N6-methyladenosine-induced ERRγ Triggers Chemoresistance of Cancer Cells Through Upregulation of ABCB1 and Metabolic Reprogramming: Erratum.

Erratum - MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.

Correction: Cepharanthine Hydrochloride Reverses the Mdr1 (P-Glycoprotein)-mediated Esophageal Squamous Cell Carcinoma Cell Cisplatin Resistance Through JNK and P53 Signals

Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.

Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients

Erratum: The lncRNA HOXA11-AS Regulates Rab3D Expression by Sponging miR-125a-5p Promoting Metastasis of Osteosarcoma [Corrigendum]